Welcome to Acucela
Acucela is leveraging promising science in visual cycle modulation to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide.
Innovative Approach
Acucela’s visual cycle modulators selectively target cells within the retina to protect visual acuity and have the potential to be used to treat several devastating eye diseases, including dry age-related macular degeneration (AMD).
Executive Videos
At Acucela we believe that all people deserve the right to sight. Hear from our leadership team about how Acucela is poised to shape the future of eye disease therapies for people around the world.